Eprosartan

CAS 133040-01-4

Overview

Eprosartan is an angiotensin II receptor antagonist used for the treatment of high blood pressure. It is marketed in the United States as Teveten by Abbvie, the spin-off of the pharmaceutical discovery division of Abbott Laboratories; it is marketed as Eprozar by Intas Pharmaceuticals in India, and by Abbott Laboratories elsewhere. The compound came into the Abbott Laboratories cardiovascular pipeline with its acquisition of Kos Pharmaceuticals in 2006, which had licensed it, along with "a range of hypertensive treatments", from the Biovail Corporation

Anant Labs manufacture and furnish high quality Eprosartan impurities for global markets. Our Eprosartan EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Eprosartan

Cat. No. ANTPRD5766Old No. ANT-EPR-00CAS 133040-01-4In Stock

Technical Data

New Cat. No.ANTPRD5766

Old Cat. No.ANT-EPR-00

CAS133040-01-4

Mol. FormulaC₂₃H₂₄N₂O₄S

Mol. Weight424.51 g/mol

IUPAC4-[[2-butyl-5-[(E)-2-carboxy-3-thiophen-2-ylprop-1-enyl]imidazol-1-yl]methyl]benzoic acid

SMILESCCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)/C=C(\CC3=CC=CS3)/C(=O)O

InChIInChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+

InChI KeyOROAFUQRIXKEMV-LDADJPATSA-N

Synonyms

(alphaE)-alpha-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-2-thiophenepropanoic Acid(E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic AcidEprosartan133040-01-4SK&F 108566SK&F-108566SKF-1085662KH13Z0S0YSK-108566CHEBI:4814